End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-10 pm EDT
|
5-day change
|
1st Jan Change
|
6.49
CNY
|
+1.72%
|
|
-0.61%
|
-15.05%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,651
|
4,648
|
6,781
|
3,551
|
2,947
|
-
|
-
|
Enterprise Value (EV)
1 |
3,651
|
4,648
|
6,781
|
3,551
|
2,947
|
2,947
|
2,947
|
P/E ratio
|
24.5
x
|
21.8
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
1.09%
|
-
|
1.51%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.33
x
|
-
|
2.28
x
|
1.49
x
|
1.08
x
|
0.91
x
|
0.77
x
|
EV / Revenue
|
2.33
x
|
-
|
2.28
x
|
1.49
x
|
1.08
x
|
0.91
x
|
0.77
x
|
EV / EBITDA
|
-
|
-
|
-
|
8.58
x
|
6.32
x
|
4.89
x
|
3.89
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.85
x
|
-
|
3.31
x
|
1.64
x
|
1.3
x
|
1.25
x
|
1.15
x
|
Nbr of stocks (in thousands)
|
445,601
|
465,785
|
465,089
|
464,756
|
464,756
|
-
|
-
|
Reference price
2 |
8.193
|
9.978
|
14.58
|
7.640
|
6.490
|
6.490
|
6.490
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,569
|
-
|
2,970
|
2,390
|
2,739
|
3,246
|
3,850
|
EBITDA
1 |
-
|
-
|
-
|
413.8
|
466
|
603
|
757
|
EBIT
1 |
180
|
-
|
-
|
215.1
|
235
|
342
|
467
|
Operating Margin
|
11.47%
|
-
|
-
|
9%
|
8.58%
|
10.53%
|
12.13%
|
Earnings before Tax (EBT)
|
173.7
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
149.8
|
213.6
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
9.54%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.3348
|
0.4578
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
0.0889
|
-
|
0.2200
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
804.7
|
742.2
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
|
-
|
-
|
Net margin
|
-
|
-
|
EPS
|
-
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
3/29/23
|
4/26/23
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12.2%
|
-
|
23%
|
9.24%
|
9.01%
|
12.7%
|
16%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
11.7%
|
4.85%
|
5%
|
6.8%
|
8.9%
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
1 |
2.880
|
-
|
4.400
|
4.660
|
4.990
|
5.210
|
5.640
|
Cash Flow per Share
|
0.5700
|
-
|
1.110
|
-
|
-
|
-
|
-
|
Capex
2 |
155
|
-
|
-
|
349
|
271
|
281
|
261
|
Capex / Sales
|
9.85%
|
-
|
-
|
14.61%
|
9.89%
|
8.66%
|
6.78%
|
Announcement Date
|
2/27/20
|
3/30/22
|
3/29/23
|
3/29/24
|
-
|
-
|
-
|
Last Close Price
6.49
CNY Average target price
7
CNY Spread / Average Target +7.86% Consensus |
1st Jan change
|
Capi.
|
---|
| -15.05% | 416M | | -14.24% | 3.03B | | -43.74% | 1.51B | | -19.66% | 1.46B | | -13.93% | 1.46B | | -34.15% | 1.41B | | -11.69% | 1.17B | | -8.35% | 1.04B | | +61.10% | 918M | | -33.75% | 875M |
Pesticide
|